{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:47Z","timestamp":1786119587177,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/wnf.0b013e318210ece0","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T11:34:33Z","timestamp":1298720073000},"page":"79-83","source":"Crossref","is-referenced-by-count":17,"title":["Adverse Reactions to Antiepileptic Drugs in Epileptic Outpatients"],"prefix":"10.1097","volume":"34","author":[{"given":"Soha","family":"Namazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Borhani-Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Karimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1046\/j.1528-1157.2001.22001.x","article-title":"Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology.","volume":"42","author":"Blume","year":"2001","journal-title":"Epilepsia"},{"key":"R2-6-20210203","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1192\/bjp.184.1.70","article-title":"Mental health survey of the adult population in Iran.","volume":"184","author":"Noorbala","year":"2004","journal-title":"Br J Psychiatry"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.seizure.2006.05.011","article-title":"Prevalence of epilepsy and comorbidity of psychiatric disorders in Iran.","volume":"15","author":"Mohammadi","year":"2006","journal-title":"Seizure"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0920-1211(00)00124-8","article-title":"Assessing risk to benefit ratio in antiepileptic drug therapy.","volume":"41","author":"Perucca","year":"2000","journal-title":"Epilepsy Res"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/pds.1540","article-title":"Pattern of adverse drug reactions to anti-epileptic drugs: a cross-sectional one-year survey at a tertiary care hospital.","volume":"17","author":"Roopa","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000081920","article-title":"Preliminary study on the efficacy and tolerability of newer anticonvulsants in a population of epileptic patients.","volume":"14","author":"Guevara","year":"2005","journal-title":"Med Princ Pract"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clineuro.2009.12.014","article-title":"Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.","volume":"112","author":"Zeng","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"R11-6-20210203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.nrl.0000256353.14257.7c","article-title":"A new look at the second-generation antiepileptic drugs: a decade of experience.","volume":"13","author":"LaRoche","year":"2007","journal-title":"Neurologist"},{"key":"R12-6-20210203","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management.","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00002018-199716060-00002","article-title":"Principles of signal detection in pharmacovigilance.","volume":"16","author":"Meyboom","year":"1997","journal-title":"Drug Saf"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R16-6-20210203","first-page":"538","article-title":"Focusing on the preventability of adverse drug reactions.","volume":"27","author":"Schumock","year":"1992","journal-title":"Hosp Pharm"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1383\/medc.31.8.20.27683","article-title":"Adverse drug reactions.","volume":"31","author":"Ferner","year":"2003","journal-title":"Medicine"},{"key":"R18-6-20210203","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/pds.1916","article-title":"Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patients.","volume":"19","author":"Mohebbi","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-6-20210203","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy.","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1528-1157.1997.tb01128.x","article-title":"Quality of life of people with epilepsy: a European study.","volume":"38","author":"Baker","year":"1997","journal-title":"Epilepsia"},{"key":"R21-6-20210203","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1528-1167.2010.02520.x","article-title":"Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy.","volume":"51","author":"Canevini","year":"2010","journal-title":"Epilepsia"},{"key":"R23-6-20210203","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1528-1167.2007.01041.x","article-title":"Idiosyncratic adverse reactions to antiepileptic drugs.","volume":"48","author":"Zaccara","year":"2007","journal-title":"Epilepsia"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0920-1211(01)00306-0","article-title":"Life-threatening adverse events of antiepileptic drugs.","volume":"47","author":"Arroyo","year":"2001","journal-title":"Epilepsy Res"},{"key":"R26-6-20210203","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.291.5.605","article-title":"The new antiepileptic drugs: scientific review.","volume":"291","author":"LaRoche","year":"2004","journal-title":"JAMA"},{"key":"R27-6-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9150","article-title":"Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.","volume":"9","author":"Wilby","year":"2005","journal-title":"Health Technol Assess"},{"key":"R28-6-20210203","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.eplepsyres.2005.07.017","article-title":"Pharmacological and clinical aspects of antiepileptic drug use in the elderly.","volume":"68","author":"Perucca","year":"2006","journal-title":"Epilepsy Res"},{"key":"R29-6-20210203","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.yebeh.2005.06.001","article-title":"Treatment of epilepsy in adults: expert opinion, 2005.","volume":"7","author":"Karceski","year":"2005","journal-title":"Epilepsy Behav"},{"key":"R30-6-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1157.1992.tb02281.x","article-title":"Prognosis of epilepsy in newly referred patients: a multicenter prospective study of the effects of monotherapy on the long-term course of epilepsy. Collaborative Group for the Study of Epilepsy.","volume":"33","author":"Beghi","year":"1992","journal-title":"Epilepsia"},{"key":"R31-6-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1981.tb04327.x","article-title":"Monotherapy or polytherapy for epilepsy?","volume":"22","author":"Reynolds","year":"1981","journal-title":"Epilepsia"},{"key":"R32-6-20210203","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bmj.285.6339.423","article-title":"Effect of reduction of anticonvulsants on wellbeing.","volume":"285","author":"Fischbacher","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R33-6-20210203","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1600-0404.2003.00151.x","article-title":"Factors affecting the quality of life in patients with epilepsy in Seoul, South Korea.","volume":"108","author":"Choi-Kwon","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"R34-6-20210203","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s11136-008-9375-9","article-title":"Association of demographic, clinical and treatment variables with quality of life of patients with epilepsy in Greece.","volume":"17","author":"Piperidou","year":"2008","journal-title":"Qual Life Res"},{"key":"R35-6-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2003.09.007","article-title":"Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial.","volume":"57","author":"Beghi","year":"2003","journal-title":"Epilepsy Res"},{"key":"R36-6-20210203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2006.01.010","article-title":"Factors associated with generic and disease-specific quality of life in temporal lobe epilepsy.","volume":"69","author":"Meldolesi","year":"2006","journal-title":"Epilepsy Res"},{"key":"R37-6-20210203","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.seizure.2006.10.011","article-title":"Factors influencing on quality of life in people with epilepsy.","volume":"16","author":"Guekht","year":"2007","journal-title":"Seizure"},{"key":"R38-6-20210203","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0404.1997.tb00106.x","article-title":"Adverse effects in epilepsy therapy. Wait and see or go for it?","volume":"95","author":"Deckers","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"R39-6-20210203","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.seizure.2006.02.009","article-title":"A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with anti-epileptic drugs.","volume":"15","author":"Uijl","year":"2006","journal-title":"Seizure"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e318210ece0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:55:18Z","timestamp":1786042518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201103000-00006"}},"subtitle":["A Cross-Sectional Study in Iran"],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e318210ece0","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}